©The Author(s) 2025.
World J Hepatol. Oct 27, 2025; 17(10): 110430
Published online Oct 27, 2025. doi: 10.4254/wjh.v17.i10.110430
Published online Oct 27, 2025. doi: 10.4254/wjh.v17.i10.110430
Table 1 Summary of baseline characteristics by sex and age group, n (%)
| Parameter | Category | 15-44 years | 45-55 years | > 55 years | |||
| Women (n = 3118) | Men (n = 4163) | Women (n = 1689) | Men (n = 2185) | Women (n = 4650) | Men (n = 3181) | ||
| BMI | Median | 23.23 | 25.88 | 25.15 | 26.54 | 26.17 | 26.47 |
| Genotype | 1 | 69 (2.21) | 69 (1.66) | 32 (1.89) | 34 (1.56) | 115 (2.47) | 62 (1.95) |
| 1A | 269 (8.63) | 410 (9.85) | 24 (1.42) | 56 (2.56) | 53 (1.14) | 48 (1.51) | |
| 1B | 2175 (69.76) | 2616 (62.84) | 1230 (72.82) | 1404 (64.26) | 3980 (85.59) | 2600 (81.74) | |
| 2 | 8 (0.26) | 8 (0.19) | 12 (0.71) | 3 (0.14) | 16 (0.34) | 6 (0.19) | |
| 3 | 358 (11.48) | 643 (15.45) | 268 (16.87) | 437 (20) | 320 (6.88) | 319 (10.03) | |
| 4 | 175 (5.61) | 312 (7.49) | 84 (4.97) | 178 (8.15) | 87 (1.87) | 84 (2.64) | |
| 5 | 0 (0) | 0 (0) | 0 (0) | 1 (0.05) | 0 (0) | 0 (0) | |
| 6 | 1 (0.03) | 1 (0.02) | 1 (0.06) | 2 (0.09) | 0 (0) | 1 (0.03) | |
| Pangenotypic HCV drugs | 63 (2.02) | 104 (2.5) | 38 (2.25) | 70 (3.20) | 79 (1.7) | 61 (1.92) | |
- Citation: Feyissa GD. Sex-related differences in treatment outcomes of chronic hepatitis C with direct-acting antivirals. World J Hepatol 2025; 17(10): 110430
- URL: https://www.wjgnet.com/1948-5182/full/v17/i10/110430.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i10.110430